Article
Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women.
The Journal of clinical endocrinology and metabolism - 1 Jun 2005
Fan Yue-Mei, Dastidar Prasun, Jokela Hannu, Punnonen Reijo, Lehtimäki Terho
Abstract excerpt
Hepatic lipase (HL) is a lipolytic enzyme that hydrolyzes triglycerides and phospholipids in almost all major classes of lipoproteins. The HL gene has a functional promoter polymorphism at position -480, which affects transcription and leads to CC, CT, and TT genotypes. We investigated the effect of long-term hormone replacement therapy (HRT) on the progression of atherosclerosis in a 5-yr follow-up observational...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
